Adrenoleukodystrophy epidemiology and demographics: Difference between revisions
Ibtisamshrf (talk | contribs) |
Ibtisamshrf (talk | contribs) |
||
| Line 9: | Line 9: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | |||
*Adrenoleukodystrophy is the most common peroxisomal disorder, with an estimated '''incidence''' of 1 in 17,000 births (male and female) and 1 in 21,000 males in the United States. <ref name="pmid31074578">{{cite journal| author=Wiens K, Berry SA, Choi H, Gaviglio A, Gupta A, Hietala A | display-authors=etal| title=A report on state-wide implementation of newborn screening for X-linked Adrenoleukodystrophy. | journal=Am J Med Genet A | year= 2019 | volume= 179 | issue= 7 | pages= 1205-1213 | pmid=31074578 | doi=10.1002/ajmg.a.61171 | pmc=6619352 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31074578 }} </ref> | *Adrenoleukodystrophy is the most common peroxisomal disorder, with an estimated '''incidence''' of 1 in 17,000 births (male and female) and 1 in 21,000 males in the United States. <ref name="pmid31074578">{{cite journal| author=Wiens K, Berry SA, Choi H, Gaviglio A, Gupta A, Hietala A | display-authors=etal| title=A report on state-wide implementation of newborn screening for X-linked Adrenoleukodystrophy. | journal=Am J Med Genet A | year= 2019 | volume= 179 | issue= 7 | pages= 1205-1213 | pmid=31074578 | doi=10.1002/ajmg.a.61171 | pmc=6619352 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31074578 }} </ref> | ||
===Prevalence=== | |||
*The '''prevalence''' of X-linked adrenoleukodystrophy is approximately 1 in 20,000 individuals. This condition occurs with a similar frequency in all populations. | *The '''prevalence''' of X-linked adrenoleukodystrophy is approximately 1 in 20,000 individuals. This condition occurs with a similar frequency in all populations. | ||
Revision as of 18:18, 23 June 2020
|
Adrenoleukodystrophy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Adrenoleukodystrophy epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Adrenoleukodystrophy epidemiology and demographics |
|
Adrenoleukodystrophy epidemiology and demographics in the news |
|
Risk calculators and risk factors for Adrenoleukodystrophy epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Adrenoleukodystrophy is the most common peroxisomal disorder, with an estimated incidence of 1 in 17,000 births (male and female) and 1 in 21,000 males in the United States. The prevalence of X-linked adrenoleukodystrophy is approximately 1 in 20,000 individuals. This condition occurs with a similar frequency in all populations. The lifetime prevalence of adrenal insufficiency in ALD is ~80%.
Epidemiology and Demographics
Incidence
- Adrenoleukodystrophy is the most common peroxisomal disorder, with an estimated incidence of 1 in 17,000 births (male and female) and 1 in 21,000 males in the United States. [1]
Prevalence
- The prevalence of X-linked adrenoleukodystrophy is approximately 1 in 20,000 individuals. This condition occurs with a similar frequency in all populations.
- The lifetime prevalence of adrenal insufficiency in ALD is ~80%. [2]
References
- ↑ Wiens K, Berry SA, Choi H, Gaviglio A, Gupta A, Hietala A; et al. (2019). "A report on state-wide implementation of newborn screening for X-linked Adrenoleukodystrophy". Am J Med Genet A. 179 (7): 1205–1213. doi:10.1002/ajmg.a.61171. PMC 6619352 Check
|pmc=value (help). PMID 31074578. - ↑ Huffnagel, Irene C; Laheji, Fiza K; Aziz-Bose, Razina; Tritos, Nicholas A; Marino, Rose; Linthorst, Gabor E; Kemp, Stephan; Engelen, Marc; Eichler, Florian (2019). "The Natural History of Adrenal Insufficiency in X-Linked Adrenoleukodystrophy: An International Collaboration". The Journal of Clinical Endocrinology & Metabolism. 104 (1): 118–126. doi:10.1210/jc.2018-01307. ISSN 0021-972X.